{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:20:42Z","timestamp":1775168442529,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1007\/bf00290521","type":"journal-article","created":{"date-parts":[[2004,10,5]],"date-time":"2004-10-05T02:25:38Z","timestamp":1096943138000},"page":"195-200","source":"Crossref","is-referenced-by-count":38,"title":["Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis"],"prefix":"10.1007","volume":"15","author":[{"given":"A.","family":"Schnabel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Herlyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Burchardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Reinhold-Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0049-0172(94)90027-2","volume":"23","author":"A Schnabel","year":"1994","unstructured":"Schnabel A, Gross WL (1994) Low-dose methotrexate in rheumatic diseases-efficacy, side effects, and risk factors for side effects. Semin Arthritis Rheum 23:310?327","journal-title":"Semin Arthritis Rheum"},{"key":"CR2","first-page":"760","volume":"11","author":"RN Thompson","year":"1984","unstructured":"Thompson RN, Watts C, Edelman J, Esdaile J, Russell AS (1984) A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol 11:760?763","journal-title":"J Rheumatol"},{"key":"CR3","first-page":"313","volume":"16","author":"DE Furst","year":"1989","unstructured":"Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I (1989) Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 16:313?320","journal-title":"J Rheumatol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00302669","volume":"14","author":"A Schnabel","year":"1994","unstructured":"Schnabel A, Reinhold-Keller E, Willmann V, Gross WL (1994) Tolerability of methotrexate starting with 15 or 25 mg\/week for rheumatoid arthritis. Rheumatol Int 14:33?38","journal-title":"Rheumatol Int"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries FJ, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals R, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315?324","journal-title":"Arthritis Rheum"},{"key":"CR6","first-page":"1628","volume":"17","author":"DE Furst","year":"1990","unstructured":"Furst DE, Erikson N, Clute L, Koehnke R, Burmeister LF, Kohler JA (1990) Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. J Rheumatol 17:1628?1635","journal-title":"J Rheumatol"},{"key":"CR7","first-page":"704","volume":"19","author":"EF Morand","year":"1992","unstructured":"Morand EF, McCloud PI, Littlejohn GO (1992) Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol 19:704?708","journal-title":"J Rheumatol"},{"key":"CR8","first-page":"994","volume":"17","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Hawley D, Cathey MA (1990) Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 17:994?1002","journal-title":"J Rheumatol"},{"key":"CR9","first-page":"1885","volume":"19","author":"T Pincus","year":"1992","unstructured":"Pincus T, Marcum SB, Callahan LF (1992) Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol 19:1885?1894","journal-title":"J Rheumatol"},{"key":"CR10","first-page":"639","volume":"20","author":"R Buchbinder","year":"1993","unstructured":"Buchbinder R, Hall S, Sambrook PN, Champion GD, Hartness A, Lewis D, Littlejohn GO, Miller MH, Ryan PFJ (1993) Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol 20: 639?644","journal-title":"J Rheumatol"},{"key":"CR11","first-page":"307","volume":"16","author":"CS Fehlauer","year":"1989","unstructured":"Fehlauer CS, Carson CW, Cannon GW, Ward JR, Samuelson CO, Williams HJ, Clegg DO (1989) Methotrexate therapy in rheumatoid arthritis: 2-year retrospective follow-up study. J. Rheumatol 16:307?312","journal-title":"J. Rheumatol"},{"key":"CR12","first-page":"1323","volume":"18","author":"J Sany","year":"1991","unstructured":"Sany J, Anaya JM, Lussiez V, Couret M, Combe B, Daures J-P (1991) Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases. J Rheumatol 18:1323?1327","journal-title":"J Rheumatol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/anr.1780320603","volume":"32","author":"GS Alarcon","year":"1989","unstructured":"Alarcon GS, Tracy IC, Blackburn WDJ (1989) Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 32:671?676","journal-title":"Arthritis Rheum"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/rheumatology\/28.2.147","volume":"28","author":"PS Hanrahan","year":"1989","unstructured":"Hanrahan PS, Scrivens GA, Russell AS (1989) Prospective longterm follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 28:147?153","journal-title":"Br J Rheumatol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00290296","volume":"13","author":"M Tishler","year":"1993","unstructured":"Tishler M, Caspi D, Yaron M (1993) Long-term experience with low dose methotrexate in rheumatoid arthritis. Rheumatol Int 13:103?106","journal-title":"Rheumatol Int"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.1780310501","volume":"31","author":"JM Kremer","year":"1988","unstructured":"Kremer JM, Lee JK (1988) A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Arthritis Rheum 31:577?584","journal-title":"Arthritis Rheum"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.1780350203","volume":"35","author":"JM Kremer","year":"1992","unstructured":"Kremer JM, Phelps CT (1992) Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 35:138?145","journal-title":"Arthritis Rheum"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/art.1780261015","volume":"26","author":"GW Cannon","year":"1983","unstructured":"Cannon GW, Ward JR, Clegg DO, Samuelson COJ, Abbott TM (1983) Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis. Arthritis Rheum 26:1269?1274","journal-title":"Arthritis Rheum"},{"key":"CR19","first-page":"51","volume":"21","author":"GJ Carroll","year":"1994","unstructured":"Carroll GJ, Thomas R, Phatouros CC, Atchison MH, Leslie A-L, Cook NJ, D'Souza I (1994) Incidence, prevalence and posible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 21:51?54","journal-title":"J Rheumatol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/thx.47.8.628","volume":"47","author":"MR Hargreaves","year":"1992","unstructured":"Hargreaves MR, Mowat AG, Benson MK (1992) Acute pneumonitis associated with low dose methotrexate treatment for rheumtoid arthritis: report of five cases and review of published reports. Thorax 47:628?633","journal-title":"Thorax"},{"key":"CR21","first-page":"1164","volume":"14","author":"G Searles","year":"1987","unstructured":"Searles G, McKendry RJR (1987) Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol 14:1164?1171","journal-title":"J Rheumatol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/art.1780350202","volume":"35","author":"ME Weinblatt","year":"1992","unstructured":"Weinblatt ME, Weissman BN, Holdsworth DE, Fraser PA, Maier AL, Falchuk KR, Coblyn JS (1992) Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 35:129?137","journal-title":"Arthritis Rheum"},{"key":"CR23","first-page":"973","volume":"18","author":"F Wolfe","year":"1991","unstructured":"Wolfe F, Cathey MA (1991) The effect of age on methotrexate efficacy and toxicity. J Rheumatol 18:973?977","journal-title":"J Rheumatol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.53.4.224","volume":"53","author":"MJ Veen Van der","year":"1994","unstructured":"Van der Veen MJ, van der Heide A, Kruize AA, Bijlsma JWJ (1994) Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 53:224?228","journal-title":"Ann Rheum Dis"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9343(91)80008-A","volume":"90","author":"MAS Antonelli","year":"1991","unstructured":"Antonelli MAS, Moreland LW, Brick JE (1991) Herpes zoster in patients with rheumatoid arthritis treated with weekly, lowdose methotrexate. Am J Med 90:295?298","journal-title":"Am J Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00290521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00290521\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00290521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T17:15:33Z","timestamp":1554743733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00290521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BF00290521"],"URL":"https:\/\/doi.org\/10.1007\/bf00290521","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}